Lysophosphatidic acid stimulates the proliferation of ovarian cancer cells via the gep proto-oncogene gα 12

Genes and Cancer

Volumn 2, Issue 5, 2011, Pages 563-575

  Goldsmith, Zachariah G ^a,b   Ha, Ji Hee ^b   Jayaraman, Muralidharan ^b   Dhanasekaran, Danny N ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

gep; LPA; metastasis; oncogene; proliferation

Indexed keywords

LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; SHORT HAIRPIN RNA;

ARTICLE; CANCER CELL CULTURE; CELL ACTIVATION; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MITOGENICITY; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; OVARY CANCER; PRIORITY JOURNAL; PROTO ONCOGENE; PROTO ONCOGENE G ALPHA 12;

EID: 80053027028     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601911419362     Document Type: Article

References (39)

1. Jemal A,Siegel R,Xu J,Ward E.Cancer statistics, 2010.CA Cancer J Clin. 2010;60:277-300.
2. Mills GB,May C,McGill M,Roifman CM,Mellors A.A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action.Cancer Res. 1998;48:1066-71.
3. Xu Y,Fang XJ,Casey G,Mills GB.Lysophospholipids activate ovarian and breast cancer cells.Biochem J. 1995;309:933-40.
4. Fishman DA,Liu Y,Ellerbroek SM,Stack MS.Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells.Cancer Res. 2001;61:3194-9.
5. Sawada K,Morishige K,Tahara M, et al.Alendronate inhibits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of rho.Cancer Res. 2002;62:6015-20.
6. Memarzadeh S,Berek JS.Advances in the management of epithelial ovarian cancer.J Reprod Med. 2001;46:621-9.
7. Radhika V,Dhanasekaran N.Transforming G proteins.Oncogene. 2001;20:1607-14.
8. Xu Y,Shen Z,Wiper DW, et al.Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers.JAMA. 1998;280:719-23.
9. Xiao YJ,Schwartz B,Washington M, et al.Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids.Anal Biochem. 2001;290:302-13.
10. Baker DL,Desiderio DM,Miller DD,Tolley B,Tigyi GJ.Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry.Anal Biochem. 2001;292:287-95.
11. Sutphen R,Xu Y,Wilbanks GD, et al.Lysophospholipids are potential biomarkers of ovarian cancer.Cancer Epidemiol Biomarkers Prev. 2004;13:1185-91.
12. Kumar RN,Ha JH,Radhakrishnan R,Dhanasekaran DN.Transactivation of platelet-derived growth factor receptor alpha by the GTPase-deficient activated mutant of Gα12.Mol Cell Biol. 2006;26:50-62.
13. Xie L,Frank PG,Lisanti MP,Sowa G.Endothelial cells isolated from caveolin-2 knockout mice display higher proliferation rate and cell cycle progression relative to their wild-type counterparts.Am J Physiol Cell Physiol. 2010;298:C693-701.
14. Orsulic S,Li Y,Soslow RA,Vitale-Cross LA,Gutkind JS,Varmus HE.Induction of ovarian cancer by defined multiple genetic changes in a mouse model system.Cancer Cell. 2002;1:53-62.
15. Radhakrishnan R,Ha JH,Dhanasekaran DN.Mitogenic signaling by the gep oncogene involves the upregulation of S-phase kinase-associated protein 2.Genes Cancer. 2010;1:1033-43.
16. Moolenaar WH,Kranenburg O,Postman FR,Zondag GC.Lysophosphatidic acid: G-protein signalling and cellular responses.Curr Opin Cell Biol. 1997;9:168-73.
17. Goetzl EJ,Dolezalova H,Kong Y, et al.Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer.Cancer Res. 1999;59:5370-5.
18. Pustilnik TB,Estrella V,Wiener JR, et al.Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.Clin Cancer Res. 1999;5:3704-10.
19. Hu YL,Tee MK,Goetzl EJ, et al.Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.J Natl Cancer Inst. 2001;93:762-8.
20. Hu YL,Albanese C,Pestell RG,Jaffe RB.Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.J Natl Cancer Inst. 2003;95:733-40.
21. Yu S,Murph MM,Lu Y, et al.Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells.J Natl Cancer Inst. 2008;100:1630-42.
22. Goldsmith ZG,Dhanasekaran DN.G protein regulation of MAPK networks.Oncogene. 2007;26:3122-42.
23. Yamaguchi Y,Katoh H,Mori K,Negishi M.Gα12 and Gα13 interact with Ser/Thr protein phosphatase type 5 and stimulate its phosphatase activity.Curr Biol. 2002;12:1353-8.
24. Yamaguchi Y,Katoh H,Negishi M.N-terminal short sequences of alpha subunits of the G12 family determine selective coupling to receptors.J Biol Chem. 2003;278:14936-9.
25. Eder AM,Sasagawa T,Mao M,Aoki J,Mills GB.Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2.Clin Cancer Res. 2000;6:2482-91.
26. Umezu-Goto M,Kishi Y,Taira A, et al.Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production.J Cell Biol. 2002;158:227-33.
27. Tanyi JL,Hasegawa Y,Lapushin R, et al.Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer.Clin Cancer Res. 2003;9:3534-45.
28. Gilchrist A,Mazzoni MR,Dineen B, et al.Antagonists of the receptor-G protein interface block Gi-coupled signal transduction.J Biol Chem. 1998;273:14912-9.
29. Gilchrist A,Vanhauwe JF,Li A,Thomas TO,Voyno-Yasenetskaya T,Hamm HE.Gα minigenes expressing C-terminal peptides serve as specific inhibitors of thrombin-mediated endothelial activation.J Biol Chem. 2001;276:25672-9.
30. Chan AM,Fleming TP,McGovern ES,Chedid M,Miki T,Aaronson SA.Expression cDNA cloning of a transforming gene encoding the wild-type Gα12 gene product.Mol Cell Biol. 1993;13:762-8.
31. Xu N,Bradley L,Ambdukar I,Gutkind JS.A mutant α subunit of G12 potentiates the eicosanoid pathway and is highly oncogenic in NIH 3T3 cells.Proc Natl Acad Sci U S A. 1993;90:6741-5.
32. Voyno-Yasenetskaya TA,Pace AM,Bourne HR.Mutant α subunits of G12 and G13 proteins induce neoplastic transformation of Rat-1 fibroblasts.Oncogene. 1994;9:2559-65.
33. Tolkacheva T,Feuer B,Lorenzi MV,Saez R,Chan AM.Cooperative transformation of NIH3T3 cells by Gα12 and Rac1.Oncogene. 1997;15:727-35.
34. Radhika V,Ha JH,Jayaraman M,Tsim ST,Dhanasekaran N.Mitogenic signaling by lysophosphatidic acid (LPA) involves Gα12.Oncogene. 2005;24:4597-603.
35. Hama K,Aoki J.LPA3, a unique G protein-coupled receptor for lysophosphatidic acid.Prog Lipid Res. 2010;49:335-42.
36. Jin Y,Zhang H,Tsao SW, et al.Cytogenetic and molecular genetic characterization of immortalized human ovarian surface epithelial cell lines: consistent loss of chromosome 13 and amplification of chromosome 20.Gynecol Oncol. 2004;92:183-91.
37. Dermott JM,Dhanasekaran N.Determining cellular role of Gα12.Methods Enzymol. 2002;344:298-309.
38. Shan D,Chen L,Wang D,Tan YC,Gu JL,Huang XY.The G protein Gα13 is required for growth factor-induced cell migration.Dev Cell. 2006;10:707-18.
39. Radhika V,Onesime D,Ha JH,Dhanasekaran N.Gα13 stimulates cell migration through cortactin-interacting protein Hax-1.J Biol Chem. 2004;279:49406-13.